1-7 of 7
Kyu-Tae Kim, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single-Cell Multi-Omics Reveals Distinct Paths to Survival of Admixed BTK C481 Mutant Vs. Wild-Type Cells in Clinically Progressing Chronic Lymphocytic Leukemia

Andrew Lipsky, MD, Danny Luan, MPH, Shirley Chen, BSc, Ronan Chaligne, PhD, Neville Dusaj, MS, Erica B Bhavsar, BS, Chelston Ang, MS, Anna S Nam, MD, Federico Gaiti, PhD, Paulina Chamely, MSc, Nathaniel D. Omans, MS, Preeti Trisal, MS, Anita K Gandhi, PhD, Kyu-Tae Kim, PhD, Rafael Schulman, BS, Joshua S. Schiffman, PhD, Franco Izzo, PhD, Gregory Mullokandov, MD PhD, Chingiz Underbayev, MD PhD, Adrian Wiestner, MD PhD, John N. Allan, MD, Richard R. Furman, MD, Dan A. Landau, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–42.
https://doi.org/10.1182/blood-2020-138374
Published: 2020
Journal Articles

PHI-101 Is a Potent Third-Generation FLT3 Inhibitor Developed to Overcome Resistance in Acute Myeloid Leukemia

Ky-Youb Nam, PhD, Jeejin Im, June H-J H-J Han, Kyu-Tae Kim, PhD, Jeong-Hyeok Yoon, PhD, Hanna Cho, PhD, Seung-Hye Choi, PhD, David Young, MD, Bao Nguyen, Ruiqi Zhu, PhD, Li Li, MD,PhD, Donald Small, MD, PhD, Taebo Sim, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28.
https://doi.org/10.1182/blood-2020-139044
Published: 2020
Journal Articles

High Throughput Droplet Single-Cell Genotyping of Transcriptomes (GoT) Reveals the Cell Identity Dependency of the Transcriptional Output of Somatic Mutations

Anna S Nam, MD, Kyu-Tae Kim, PhD, Ronan Chaligne, PhD, Franco Izzo, PhD, Chelston Ang, MS, Nathaniel Omans, MS, Alessandro Pastore, Justin Taylor, MD, Alicia Alonso, Wayne Tam, MD PhD, Ronald Hoffman, MD, Joseph Scandura, MDPhD, Raul Rabadan, PhD, Omar I Abdel-Wahab, MD, Peter Smibert, PhD, Dan A. Landau, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 541.
https://doi.org/10.1182/blood-2018-99-119236
Published: 2018
Journal Articles

Prolonged Exposure to FLT3 Inhibitors Leads to Resistance Via Activation of Parallel Signaling Pathways.

Obdulio Piloto, PhD, Melissa Wright, BS, Patrick Brown, MD, Kyu-Tae Kim, PhD, Mark Levis, MD/PhD, Donald Small, MD/PhD
Journal: Blood
Blood (2006) 108 (11): 1380.
https://doi.org/10.1182/blood.V108.11.1380.1380
Published: 2006
Journal Articles

Bad Phosphorylation Is Reduced in Response to Inhibition of Constitutively Activated FLT3.

Kyu-Tae Kim, PhD, Mark Levis, MD, PhD, Donald Small, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1367.
https://doi.org/10.1182/blood.V106.11.1367.1367
Published: 2005
Journal Articles

FLT3 Inhibitor Resistant Cells Show Different Downstream Signaling Pathway Changes.

Kyu-Tae Kim, PhD, Obdulio Piloto, BS, Donald Small, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 4381.
https://doi.org/10.1182/blood.V106.11.4381.4381
Published: 2005
Journal Articles

FLT3 Immunotherapy Can Eliminate Engraftment of ALL Cells in NOD/SCID Mice.

Obdulio Piloto, BS, Bao Nguyen, MS, Patrick Brown, MD, Kyu-Tae Kim, PhD, David Huso, PhD, Yiwen Li, PhD, Larry Witte, PhD, Daniel J. Hicklin, PhD, Donald Small, MD/PhD
Journal: Blood
Blood (2005) 106 (11): 869.
https://doi.org/10.1182/blood.V106.11.869.869
Published: 2005